Tetanus toxoid-specific CD4+ T-cell receptor (TT-specific TCR)

CD4+ T-cell receptors (TCRs) recognizing tetanus peptide–MHC class II complexes are specialized protein complexes on the surface of helper T lymphocytes that mediate the adaptive immune response to Clostridium tetani (PMID: 15507523). These receptors specifically bind to immunodominant peptides, such as p2 or p30, derived from the tetanus toxoid when presented by Major Histocompatibility Complex (MHC) class II molecules, typically HLA-DR (PMID: 2463457). This interaction is the primary target of tetanus vaccinations, which aim to stimulate these TCRs to induce long-term immunological memory and B-cell help for antibody production (PubMed: 10508254). Upon binding, the TCR complex initiates intracellular signaling through the CD3 complex, leading to T-cell proliferation and the secretion of pro-inflammatory cytokines like IFN-gamma and IL-2 (UniProt: P01850). In clinical settings, these TCRs are utilized as biomarkers for assessing vaccine potency and the robustness of the cellular immune system using MHC tetramer technology (PMID: 11160668). While essential for protection against tetanus, over-activation or cross-reactivity of these receptors can occasionally lead to localized hypersensitivity or Arthus-type reactions (StatPearls: Tetanus). These TCRs serve as a fundamental model in immunology for studying human T-cell memory and the mechanisms of immunodominance in response to protein antigens.

Other names

CD4+ T-cell receptors recognizing tetanus peptide–MHC class II complexesTetanus-specific T-cell receptorTetanus toxoid-reactive TCRAnti-tetanus CD4+ TCR

The target is activated by the presentation of tetanus-derived peptides on MHC class II molecules, leading to the activation and clonal expansion of CD4+ helper T cells.